Open Access. Powered by Scholars. Published by Universities.®

Digital Commons Network

Open Access. Powered by Scholars. Published by Universities.®

Articles 1 - 5 of 5

Full-Text Articles in Entire DC Network

Physiology And Advancements In Wound Healing, Adam Baker, Md Mar 2014

Physiology And Advancements In Wound Healing, Adam Baker, Md

Department of Otolaryngology - Head and Neck Surgery Presentations and Grand Rounds

Outline of presentation:

Fundamentals

Advances

  • -Growth Factors
  • -Platelet Rich Plasma
  • -Engineered skin
  • -Hyperbaric Oxygen Therapy

Research


Nasal T Cell Lymphoma: A Rare Entity, Maliha Kazi, Mubasher Ikram, Montasir Junaid Mar 2014

Nasal T Cell Lymphoma: A Rare Entity, Maliha Kazi, Mubasher Ikram, Montasir Junaid

Section of Otolaryngology, Head & Neck Surgery

Nasal type of Natural Killer (NK)/T cell lymphoma manifests in the nasal cavity. Approximately 95% of them are associated with EBV(Ebstein Barr Virus) with a strong predilection for the Asian population. It has certain systemic and localized symptoms which aid in diagnosis of the condition. However, the histological criteria is pivotal in confirming the diagnosis as well as aiding in confirming the association of EBV. Nasal type of NK/T cell lymphoma has a guarded prognosis. Treatment plan include radiotherapy with concurrent chemotherapy. Despite all this, the 5-year survival rate ranges from 15-75%. A 35 years old male presented with an …


Laryngeal Myxoma: A Case Report And Review Of The Literature, A. Ritchie, J. Youngerman, J. E. Fantasia, L. B. Kahn, R. S. Cocker Jan 2014

Laryngeal Myxoma: A Case Report And Review Of The Literature, A. Ritchie, J. Youngerman, J. E. Fantasia, L. B. Kahn, R. S. Cocker

Journal Articles

Myxomas are a rare benign neoplasm of uncertain mesenchymal cell origin, typically involving the heart. Laryngeal myxomas are uncommon, and are usually misdiagnosed as laryngeal polyp. To the best of our knowledge, there are only nine reported cases in the English literature. We report a case of a laryngeal myxoma presenting clinically as a left vocal cord polyp in a 77 year old male, and review the literature related to this rare entity.


Decreased Langerhans Cell Responses To Il-36 Gamma: Altered Innate Immunity In Patients With Recurrent Respiratory Papillomatosis, J. Devoti, L. Hatam, A. Lucs, A. Afzal, A. Abramson, B. M. Steinberg, V. Bonagura Jan 2014

Decreased Langerhans Cell Responses To Il-36 Gamma: Altered Innate Immunity In Patients With Recurrent Respiratory Papillomatosis, J. Devoti, L. Hatam, A. Lucs, A. Afzal, A. Abramson, B. M. Steinberg, V. Bonagura

Journal Articles

Recurrent respiratory papillomatosis (RRP) is a rare, chronic disease caused by human papillomaviruses (HPVs) types 6 and 11 that is characterized by the polarization of adaptive immune responses that support persistent HPV infection. Respiratory papillomas express elevated mRNA levels of IL-36 gamma, a proinflammatory cytokine in comparison to autologous clinically normal laryngeal tissues; however there is no evidence of inflammation in these lesions. Consistent with this, respiratory papillomas do not contain T(H)1-like CD4(+) T-cells or cytotoxic CD8(+) T-cells, but instead contain a predominance of T(H)2-like and T regulatory cells (Tregs). In addition, papillomas also are infiltrated with immature Langerhans cells …


Malignancy Rate In Thyroid Nodules Classified As Bethesda Category Iii (Aus/Flus), A. S. Ho, E. E. Sarti, K. S. Jain, H. J. Wang, I. J. Nixon, A. R. Shaha, J. P. Shah, D. Kraus, R. Ghossein, L. G. T. Morris, +3 Addiltional Authors Jan 2014

Malignancy Rate In Thyroid Nodules Classified As Bethesda Category Iii (Aus/Flus), A. S. Ho, E. E. Sarti, K. S. Jain, H. J. Wang, I. J. Nixon, A. R. Shaha, J. P. Shah, D. Kraus, R. Ghossein, L. G. T. Morris, +3 Addiltional Authors

Journal Articles

Background: The Bethesda System for Reporting Thyroid Cytopathology is the standard for interpreting fine needle aspiration (FNA) specimens. The atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS) category, known as Bethesda Category III, has been ascribed a malignancy risk of 5-15%, but the probability of malignancy in AUS/FLUS specimens remains unclear. Our objective was to determine the risk of malignancy in thyroid FNAs categorized as AUS/FLUS at a comprehensive cancer center. Methods: The management of 541 AUS/FLUS thyroid nodule patients treated at Memorial Sloan-Kettering Cancer Center between 2008 and 2011 was analyzed. Clinical and radiologic features were examined as …